Craniofacial Pain in COVID‐19 Patients with Diabetes Mellitus: Clinical and Laboratory Description of Twenty‐One Cases
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F21%3A00121124" target="_blank" >RIV/00216224:14110/21:00121124 - isvavai.cz</a>
Výsledek na webu
<a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26866" target="_blank" >https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26866</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/jmv.26866" target="_blank" >10.1002/jmv.26866</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Craniofacial Pain in COVID‐19 Patients with Diabetes Mellitus: Clinical and Laboratory Description of Twenty‐One Cases
Popis výsledku v původním jazyce
The pandemicity of diabetes mellitus (DM) has always been a challenging concern for oral and maxillofacial practitioners which got aggravated by the coronavirus disease (COVID‐19) pandemic. DM is an independent risk factor for COVID‐19 morbidity and mortality; on the other hand, COVID‐19 outbreak has deteriorated the access of diabetic patients to palliative care and limited their outdoor activities and their nutrition. Similar to the Severe Acute Respiratory Syndrome (SARS) and the Middle Eastern Respiratory Syndrome (MERS), COVID‐19 is strongly associated with altered glycemic levels thus leading in some cases to new‐onset diabetes. In accordance with the CARE guidelines, we aim to report the characteristics of twenty‐one consecutive diabetic type‐2 COVID‐19 patients who presented to our department from April to August 2020 with throbbing craniofacial pain.
Název v anglickém jazyce
Craniofacial Pain in COVID‐19 Patients with Diabetes Mellitus: Clinical and Laboratory Description of Twenty‐One Cases
Popis výsledku anglicky
The pandemicity of diabetes mellitus (DM) has always been a challenging concern for oral and maxillofacial practitioners which got aggravated by the coronavirus disease (COVID‐19) pandemic. DM is an independent risk factor for COVID‐19 morbidity and mortality; on the other hand, COVID‐19 outbreak has deteriorated the access of diabetic patients to palliative care and limited their outdoor activities and their nutrition. Similar to the Severe Acute Respiratory Syndrome (SARS) and the Middle Eastern Respiratory Syndrome (MERS), COVID‐19 is strongly associated with altered glycemic levels thus leading in some cases to new‐onset diabetes. In accordance with the CARE guidelines, we aim to report the characteristics of twenty‐one consecutive diabetic type‐2 COVID‐19 patients who presented to our department from April to August 2020 with throbbing craniofacial pain.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10607 - Virology
Návaznosti výsledku
Projekt
<a href="/cs/project/LTC20031" target="_blank" >LTC20031: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Medical Virology
ISSN
0146-6615
e-ISSN
1096-9071
Svazek periodika
93
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
4
Strana od-do
2616-2619
Kód UT WoS článku
000618038400001
EID výsledku v databázi Scopus
2-s2.0-85101475412